Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Cigna / Eysuvis Loteprednol Etabonate 0 25 Ophthalmic Suspension

Eysuvis Loteprednol Etabonate 0 25 Ophthalmic Suspension — Cigna

1 indication indexed for this drug.

Dry Eye Disease Short Term Treatment
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.